1365 results
Transcatheter aortic valve replacement with self-expanding ACURATE neo2
20 Jun 2022
This study investigated the short-term safety and efficacy of the new valve ACURATE neo2 in comparison to the first neo model in a real-world population.
Reviewer
Reviewer
Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial
16 Jun 2022
The UK TAVI trial sought to compare TAVI with SAVR in patients with severe, symptomatic aortic stenosis and moderately increased surgical risk.
Reviewer
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE Neo2
09 Jun 2022
The ACURATE neo2 valve was developed to reduce the risk of paravalvular AR with an increased sealing skirt. This retrospective study aimed to compare TAVI with the ACURATE neo and neo2 devices.
Reviewer
Reviewer
Evolution and prognostic impact of cardiac damage after aortic valve replacement
24 May 2022
The aim of the current study was to describe and characterize the natural evolution of cardiac damage post-AVR and its outcomes.
Reviewer
Balloon- versus self-expanding valve systems for treating small failed surgical aortic bioprostheses: the LYTEN trial
23 May 2022
Luigi provides us with the interventional cardiologist's point of view!
Currently, TAVR selection process is performed by matching the internal diameter of the surgically implanted bioprostheses to the external diameter of commercially available TAVR devices. Nonetheless, the impact of intrinsic design differences, such as supra vs intra-annular design,...
Reviewer
EuroPCR 2022 - summaries of late-breaking science, trials and registries in Valvular Interventions and Structural Heart Disease
22 May 2022
Jonathan Curio provides his take on the new data presented at EuroPCR 2022 in Valvular Interventions and Structural Heart Disease by providing summarised key take-aways!
Author
Late-breaking science overview - What did we learn @EuroPCR 2022?
20 May 2022 – From EuroPCR 2022
Watch this video to gain insight into late-breaking studies and trials presented during EuroPCR 2022:
- Intravascular imaging vs. angiography-guided PCI in high bleeding risk patients
- Trancatheter Aortic Valve Repair for aortic insufficiency using the Cusper device
- Angiography-derived coronary microcirculatory assessment in INOCA patients
- Blood pressure and MACE reductions after renal...
Management of a patient with severe CAD and aortic valve stenosis
20 May 2022 – From EuroPCR 2022
Watch the LIVE case of an 87-year-old male patient with a history of hypertension and dyslipidemia but no other significant cardiovascular risk factors and remarkably good health for an elderly man, but with angina for some months and dyspnea, and discuss the management of TAVI candidates with...
Our patient with aortic stenosis
20 May 2022 – From EuroPCR 2022
Watch this session to improve your skills in planning TAVI procedure, performing a safe femoral access, and in performing valve implantation
Predicting and managing TAVI conduction related disorders
20 May 2022 – From EuroPCR 2022
Get key learnings on conduction disorders after TAVI, the role of temporary pacing devices and different strategies to reduce permanent pacemaker implants to the minimum.
Innovation fireworks
20 May 2022 – From EuroPCR 2022
Find out more about novel innovative techniques and devices including: Leaflex, a possible alternative to balloon valvuloplasty, Valvosoft, a non-invasive ultrasound therapy or even home blood potassium monitoring!
Abstract session for nurses and allied professionals
20 May 2022 – From EuroPCR 2022
Among the abstracts presented in this session, discover the impact of sheath size on time to hemostasis after radial interventions, find out more about telephone follow-up after discharge following TAVI, or view the answer to the question: can we avoid routine midazolam to enhance patients' cognition and knowledge?
First dedicated transcatheter leaflet splitting device from bench to first-in-man
20 May 2022 – From EuroPCR 2022
Pierre Deharo interviews Didier Tchétché on the first transcatheter leaflet splitting device (ShortCut device)which can be targeted for bicuspid aortic valves and valve-in-valve procedures.
The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI
19 May 2022 – From EuroPCR 2022
Consult this session to learn more about the characteristics of atrial fibrillation patients undergoing TAVI, the priority of stroke prevention in atrial fibrillation patients post-TAVI, as well as the current understanding in Japanese and Asian patients.
Complex heart problems in cancer patients
19 May 2022 – From EuroPCR 2022
TAVI and thrombocytopenia, TAVI, CAD and hepatocarcinoma, or even severe aortic regurgitation and ovarian cancer with infective endocarditis: analyze the case of different cancer patients to be treated for cardiac pathologies in this session from EuroPCR 2022.
What's new in TAVI - a closer look on procedural planning and device selection
19 May 2022 – From EuroPCR 2022
Streamlined TAVI with Tokyo Live @EuroPCR
19 May 2022 – From EuroPCR 2022
Watch the live case from Milan, Italy, of an 88-year-old female patient with hypertension who was admitted for dyspnoea with discovery of severe aortic stenosis to consider state-of-the-art TAVI.
The Future of TAVI
19 May 2022 – From EuroPCR 2022
Consut this session if you want to appraise the originality of the TAVI concept, to learn the feasibility of minimalist procedure and fast track patient pathway and to understand the expansion of indications and the future of TAVI.
PCR Innovators Day - Innovations for valve treatment: new devices, new tools, new procedures
19 May 2022 – From EuroPCR 2022
Valvular heart disease is probably one of the most innovative areas in cardiovascular medicine at large: tremendous progress has been made both in terms of quality of life and mortality. Technology continues to evolve, as there are still many gaps to be filled, and it is...
PCR Innovators Day - Machine learning and artificial intelligence
19 May 2022 – From EuroPCR 2022
Learn more about machine learning and artificial intelligence for automated assessment of CAD, risk assessment and early patient stratification, continuous monitoring of cardiac performance, and much more!
